Granahan Investment Management, LLC Fennec Pharmaceuticals Inc. Transaction History

Granahan Investment Management, LLC

$2.12 Billion
Q4 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$5.96 - $7.85 $1.3 Million - $1.71 Million	-217,295 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$6.21 - $8.68 $1.1 Million - $1.54 Million	-177,515 Reduced 44.96%	217,295 $1.35 Million
Q4 2020 Feb 12, 2021	SELL	$5.99 - $8.55 $219,593 - $313,443	-36,660 Reduced 8.5%	394,810 $2.94 Million
Q3 2020 Nov 12, 2020	BUY	$5.19 - $10.17 $965,822 - $1.89 Million	186,093 Added 75.84%	431,470 $2.62 Million
Q2 2020 Aug 14, 2020	SELL	$5.43 - $9.39 $134,837 - $233,172	-24,832 Reduced 9.19%	245,377 $2.05 Million
Q1 2020 May 12, 2020	SELL	$4.89 - $8.1 $565,631 - $936,935	-115,671 Reduced 29.98%	270,209 $1.61 Million
Q4 2019 Feb 14, 2020	SELL	$4.25 - $6.49 $297,920 - $454,942	-70,099 Reduced 15.37%	385,880 $2.5 Million
Q3 2019 Nov 15, 2019	BUY	$3.85 - $4.95 $65,049 - $83,635	16,896 Added 3.85%	455,979 $2.19 Million
Q2 2019 Aug 14, 2019	BUY	$3.3 - $5.09 $92,898 - $143,288	28,151 Added 6.85%	439,083 $1.76 Million
Q1 2019 May 14, 2019	BUY	$4.64 - $7.58 $213,435 - $348,672	45,999 Added 12.6%	410,932 $1.99 Million
Q4 2018 Feb 13, 2019	BUY	$5.37 - $8.39 $761,519 - $1.19 Million	141,810 Added 63.56%	364,933 $2.33 Million
Q3 2018 Nov 13, 2018	BUY	$7.84 - $10.83 $1.3 Million - $1.8 Million	166,121 Added 291.43%	223,123 $1.83 Million
Q2 2018 Aug 15, 2018	BUY	$10.05 - $14.33 $96,741 - $137,940	9,626 Added 20.32%	57,002 $595,000
Q1 2018 May 14, 2018	SELL	$8.26 - $12.1 $96,377 - $141,182	-11,668 Reduced 19.76%	47,376 $573,000
Q4 2017 Feb 12, 2018	BUY	$8.9 - $12.35 $84,113 - $116,719	9,451 Added 19.06%	59,044 $592,000
Q3 2017 Nov 14, 2017	BUY	$11.09 - $12.0 $549,986 - $595,116	49,593	49,593 $550,000

Others Institutions Holding FENC

# of Institutions

Shares Held

14.7M

Call Options Held

10K

Put Options Held

83.8K

Southpoint Capital Advisors LP New York, NY

4.08M
Shares

$26.9 Million
0.71% of portfolio
Sonic Gp LLC Honolulu, HI

2.41M
Shares

$15.9 Million
33.54% of portfolio
Solas Capital Management, LLC Darien, CT

2.25M
Shares

$14.8 Million
11.1% of portfolio
Black Rock Inc. New York, NY

1.19M
Shares

$7.82 Million
0.0% of portfolio
Dg Capital Management, LLC New York, NY

1.11M
Shares

$7.35 Million
2.94% of portfolio

View Full List

About FENNEC PHARMACEUTICALS INC.

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $172M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

More about FENC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Account